NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma
Authors:
- Concetta SaponaroCSConcetta Saponaro
- Alessandro VaghegginiAVAlessandro Vagheggini
- Emanuela ScarpiESEmanuela Scarpi
- Matteo CentonzeMCMatteo Centonze
- Ivana CatacchioICIvana Catacchio
- Ondina PopescuOPOndina Popescu
- Maria Irene PastenaMPMaria Irene Pastena
- Francesco GiottaFGFrancesco Giotta
- Nicola SilvestrisNSNicola Silvestris
- Anita MangiaAMAnita Mangia
Open Access
- 2 May 2018
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 37 (1) , 1-16
Abstract
Tumor microenvironment (TME) includes many factors such as tumor associated inflammatory cells, vessels, and lymphocytes, as well as different signaling molecules and extracellular matrix components. These aspects can be de-regulated and consequently lead to a worsening of cancer progression. In recent years an association between the scaffolding protein Na+/H+ exchanger regulatory factor 1 (NHERF1) and tumor microenvironment changes in breast cancer (BC) has been reported. Subcellular NHERF1 localization, vascular endothelial growth factor (VEGF), its receptor VEGFR1, hypoxia inducible factor 1 alpha (HIF-1α), TWIST1 expression and microvessel density (MVD) in 183 invasive BCs were evaluated, using immunohistochemistry on tissue microarrays (TMA). Immunofluorescence was employed to explore protein interactions. Cytoplasmic NHERF1(cNHERF1) expression was directly related to cytoplasmic VEGF and VEGFR1 expression (p = 0.001 and p = 0.027 respectively), and inversely to nuclear HIF-1α (p = 0.021) and TWIST1 (p = 0.001). Further, immunofluorescence revealed an involvement of tumor cells with NHERF1 positive staining in neo-vascular formation, suggesting a “mosaic” structure development of these neo-vessels. Survival analyses showed that loss of nuclear TWIST1 (nTWIST1) expression was related to a decrease of disease free survival (DFS) (p < 0.001), while nTWIST1-/mNHERF1+ presented an increased DFS with respect to nTWIST1+/mNHERF1- phenotype (p < 0.001). Subsequently, the analyses of nTWIST1+/cNHERF1+ phenotype selected a subgroup of patients with a worse DFS compared to nTWIST1-/cNHERF1- patients (p = 0.004). Resulting data suggested a dynamic relation between NHERF1 and TME markers, and confirmed both the oncosuppressor role of membranous NHERF1 expression and the oncogene activity of cytoplasmic NHERF1.Keywords
This publication has 51 references indexed in Scilit:
- VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast CancerPLOS ONE, 2013
- Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosisBMC Cancer, 2012
- Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasisJournal of Experimental & Clinical Cancer Research, 2012
- PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastomaOncogene, 2011
- Biological role of NHERF1 protein expression in breast cancerHistopathology, 2009
- Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal AdenocarcinomaPancreas, 2009
- Vasculogenic mimicry: Current status and future prospectsCancer Letters, 2007
- The NHERF1 PDZ2 Domain Regulates PKA–RhoA–p38-mediated NHE1 Activation and Invasion in Breast Tumor CellsMolecular Biology of the Cell, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003